Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Device physical property issue? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Device physical property issue have been filed in association with RIBOCICLIB (KISQALI). This represents 0.0% of all adverse event reports for RIBOCICLIB.

7
Reports of Device physical property issue with RIBOCICLIB
0.0%
of all RIBOCICLIB reports
1
Deaths
3
Hospitalizations

How Dangerous Is Device physical property issue From RIBOCICLIB?

Of the 7 reports, 1 (14.3%) resulted in death, 3 (42.9%) required hospitalization, and 3 (42.9%) were considered life-threatening.

Is Device physical property issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Device physical property issue?

SOMATROPIN (2,449) PEGFILGRASTIM (1,376) LEVONORGESTREL (506) CARBIDOPA\LEVODOPA (219) TREPROSTINIL (218) CHLORHEXIDINE\ISOPROPYL ALCOHOL (107) ADALIMUMAB (95) ESTRADIOL (89) BACLOFEN (77) ALBUTEROL (55)

Which RIBOCICLIB Alternatives Have Lower Device physical property issue Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Device physical property issue Reports All Drugs Causing Device physical property issue RIBOCICLIB Demographics